Home›People›Anna French
Anna French

Anna French

Director at Renasant Bio. Also a director at Auron Therapeutics and Entact Bio.

DirectorRoles at 3 startups
Updated Nov 9, 2026·Latest SEC filing Aug 13, 2026·Suggest an edit

About Anna French

Anna French is a director at Renasant Bio.

Form D filings also name Anna French as a director at Auron Therapeutics and Entact Bio.

Anna French first appears on SEC filings in 2020.

Experience

This experience comes from Anna French's profile and from SEC filings. For roles taken from filings, the years are when the filings name Anna French in the role, so the role may have started earlier or lasted longer.

Altis Labs Current
Board Director
2026 – Present
Renasant Bio, Inc. Current
Director
2025 – Present · Berkeley, CA
Entact Bio, Inc. Current
Director
2023 – Present · Watertown, MA
Develops medicines that enhance protein function for people with diseases.
Montage Bio Current
Board Director
2023 – Present
Empirico Inc. Current
Board Director
2023 – Present
Auron Therapeutics, Inc. Current
Director
2020 – Present · Wellesley, MA
Develops potential treatments for people with cancer and inflammatory diseases.
Umoja Biopharma Current
Board Director
2020 – Present
Qiming Venture Partners USA Current
Managing Partner
2017 – Present
Tenpoint Therapeutics Ltd
Board Director
2020 – 2024
Jasper Therapeutics
Board Director
2019 – 2024
WindMIL Therapeutics
Board Director
2018 – 2023
Talaris Therapeutics
Board Observer
2018 – 2021
Cadent Therapeutics
Board Observer
2018 – 2021
LetsGetChecked
Board Observer
2018 – 2020
The Boston Consulting Group
Management Consultant
2014 – 2017
Centre for the Advancement of Sustainable Medical Innovation (CASMI)
Manager- CASMI Translational Stem Cell Consortium
2012 – 2014
University of Oxford
Graduate Researcher
2009 – 2013

Key Colleagues at Startups

The people Anna French works with at each company, as listed on that company's latest Form D.

Auron Therapeutics, Inc. · Form D, Aug 13, 2026
Pini Orbach
Pini Orbach
Director
Serge Messerlian
Serge Messerlian
Board Director
KY
Katharine Yen
Founder & CEO, director
Entact Bio, Inc. · Form D, Jun 3, 2026
AS
Pini Orbach
Pini Orbach
Director
Victoria Richon
Victoria Richon
CEO, Board Member
RG
OS
Owen Smith
Board Member
Renasant Bio, Inc. · Form D, Jul 14, 2025
EC
Evan Caplan
Director
NH
CM
TG
Thomas Gustafson
Executive officer
KB
EC
Emily Conley
CEO and director

Sources

  1. SECAuron Therapeutics, Inc. Form D, filed Aug 13, 2026
  2. SECEntact Bio, Inc. Form D, filed Jun 3, 2026
  3. SECRenasant Bio, Inc. Form D, filed Jul 14, 2025